Literature DB >> 20723851

Angiographic and clinical outcomes among patients with acute coronary syndromes presenting with isolated anterior ST-segment depression: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis In Myocardial Infarction 38) substudy.

Yuri B Pride1, Patricia Tung, Satishkumar Mohanavelu, Cafer Zorkun, Stephen D Wiviott, Elliott M Antman, Robert Giugliano, Eugene Braunwald, C Michael Gibson.   

Abstract

OBJECTIVES: This study sought to determine angiographic and clinical outcomes among patients with acute coronary syndrome (ACS) presenting with isolated anterior ST-segment depression on 12-lead electrocardiogram (ECG).
BACKGROUND: In patients with ACS, anterior ST-segment depression on 12-lead ECG may represent plaque rupture with: 1) acute thrombotic occlusion with elevation of cardiac biomarkers (+Tn); 2) a patent artery with +Tn; or 3) a patent artery with -Tn.
METHODS: The TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel-Thrombolysis In Myocardial Infarction 38) enrolled 13,608 ACS patients. Those with isolated anterior (leads V(1) to V(4)) ST-segment depression were analyzed. Angiograms and ECGs were interpreted by local investigators.
RESULTS: There were 1,198 (8.8%) patients with isolated anterior ST-segment depression. Of those, 314 (26.2%) had an occluded culprit artery (TIMI flow grade 0/1) and +Tn, 641 (53.5%) had a patent culprit artery (TIMI flow grade 2/3) and +Tn, and 243 (20.3%) had TIMI flow grade 2/3 and -Tn. Among patients with an occluded artery, the culprit artery was most often the left circumflex artery (48.4%). The 30-day incidence of the composite of death and MI was significantly higher among patients with an occluded artery (8.6%) than among those with a patent culprit artery and either +Tn (6.3%) or -Tn (2.9%) (3-way p = 0.006). Among patients with an occluded artery, the median time from ECG to percutaneous coronary intervention was 29.4 h (interquartile range 26.1 to 44.1 h).
CONCLUSIONS: Among ACS patients presenting with isolated anterior ST-segment depression, over one-quarter had an occluded culprit artery and elevated cardiac biomarkers. These patients had significantly worse clinical outcomes, and few underwent urgent angiography. Copyright (c) 2010 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20723851     DOI: 10.1016/j.jcin.2010.05.012

Source DB:  PubMed          Journal:  JACC Cardiovasc Interv        ISSN: 1936-8798            Impact factor:   11.195


  20 in total

1.  Time for a new paradigm shift in myocardial infarction.

Authors:  Emre K Aslanger; H Pendell Meyers; Stephen W Smith
Journal:  Anatol J Cardiol       Date:  2021-03       Impact factor: 1.596

2.  Novel ECG changes in acute coronary syndromes. Would improvement in the recognition of 'STEMI-equivalents' affect time until reperfusion?

Authors:  Joshua Wall; Leigh D White; Astin Lee
Journal:  Intern Emerg Med       Date:  2016-12-31       Impact factor: 3.397

3.  A tale of two formulas: Differentiation of subtle anterior MI from benign ST segment elevation.

Authors:  Emrah Bozbeyoğlu; Emre Aslanger; Özlem Yıldırımtürk; Barış Şimşek; Can Yücel Karabay; Mustafa Aytek Şimşek; Ahmet İlker Tekkeşin; Muzaffer Değertekin; Ömer Kozan
Journal:  Ann Noninvasive Electrocardiol       Date:  2018-06-25       Impact factor: 1.468

4.  Clinical characteristics of occluded culprit arteries and collaterals in patients with non-ST-segment elevation myocardial infarction and impact on clinical outcomes.

Authors:  Hui-Jeong Hwang; Chang-Bum Park; Jin-Man Cho; Eun-Sun Jin; Il Suk Sohn; Dong-Hee Kim; Chong-Jin Kim
Journal:  Exp Ther Med       Date:  2018-08-13       Impact factor: 2.447

5.  Predictive Value of ST-Segment Elevation in Lead aVR for Left Main and/or Three-Vessel Disease in Non-ST-Segment Elevation Myocardial Infarction.

Authors:  Naoki Misumida; Akihiro Kobayashi; John T Fox; Sam Hanon; Paul Schweitzer; Yumiko Kanei
Journal:  Ann Noninvasive Electrocardiol       Date:  2015-04-17       Impact factor: 1.468

Review 6.  Antiplatelet agents for chronic kidney disease.

Authors:  Patrizia Natale; Suetonia C Palmer; Valeria M Saglimbene; Marinella Ruospo; Mona Razavian; Jonathan C Craig; Meg J Jardine; Angela C Webster; Giovanni Fm Strippoli
Journal:  Cochrane Database Syst Rev       Date:  2022-02-28

7.  Detection of acute coronary occlusion in patients with acute coronary syndromes presenting with isolated ST-segment depression.

Authors:  Mj Daly; Dd Finlay; D Guldenring; Cd Nugent; A Tomlin; B Smith; Aaj Adgey; Mt Harbinson
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2012-06

8.  Incidence and impact of totally occluded culprit coronary artery in patients with non-ST segment elevation myocardial infarction acute coronary syndrome.

Authors:  Sherif W Ayad; Tarek H El Zawawy; Mohamed I Lotfy; Ahmed M Naguib; Ahmed M El Amrawy
Journal:  Egypt Heart J       Date:  2021-04-07

9.  Ischemic ST-Segment Depression Maximal in V1-V4 (Versus V5-V6) of Any Amplitude Is Specific for Occlusion Myocardial Infarction (Versus Nonocclusive Ischemia).

Authors:  H Pendell Meyers; Alexander Bracey; Daniel Lee; Andrew Lichtenheld; Wei J Li; Daniel D Singer; Zach Rollins; Jesse A Kane; Kenneth W Dodd; Kristen E Meyers; Gautam R Shroff; Adam J Singer; Stephen W Smith
Journal:  J Am Heart Assoc       Date:  2021-11-15       Impact factor: 6.106

10.  Prasugrel Versus Ticagrelor in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: a Systematic Review and Meta-analysis of Randomized Trials.

Authors:  Avik Ray; Ahmad Najmi; Gaurav Khandelwal; Ratinder Jhaj; Balakrishnan Sadasivam
Journal:  Cardiovasc Drugs Ther       Date:  2020-08-20       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.